Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 25, 2019NeuropsychopharmacologyOpen Access

Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

YMYuya MizunoKing's College LondonRMRobert A. McCutcheonOxford Health NHS Foundation TrustSBStefan BruggerUniversity of Bristol

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mizuno et al. (2019) studied this question.

synapsesocial.com/papers/6a2204e34d10104e8b4e9795https://doi.org/10.1038/s41386-019-0577-3
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clozapine v . first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis2016 · 613 citations
  2. 2Double-Blind Comparison of Clozapine with Chlorpromazine in Acute Schizophrenic Illness1976 · 46 citations
  3. 3Fluctuation scaling in complex systems: Taylor's law and beyond12008 · 376 citations
  4. 4Clozapine and Haloperidol in Moderately Refractory Schizophrenia2001 · 178 citations
  5. 5Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses2016 · 301 citations